Published in N Engl J Med on December 02, 1999
The Norwegian Pancreas Transplantation (PTx) Study (PTx) | NCT01957696
Kidney Transplant for HIV-Infected Patients in Renal Failure | NCT00009009
Implementing "Explore Transplant"- A Pilot Study | NCT03046732
Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med (2000) 4.67
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest (2006) 3.41
How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest (2005) 2.75
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
Transplant nephrectomy improves survival following a failed renal allograft. J Am Soc Nephrol (2009) 2.56
Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54
Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol (2012) 2.30
Health literacy and access to kidney transplantation. Clin J Am Soc Nephrol (2008) 2.26
Population based screening for chronic kidney disease: cost effectiveness study. BMJ (2010) 2.19
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant (2011) 2.10
Candidacy for kidney transplantation of older adults. J Am Geriatr Soc (2012) 1.85
Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis (2012) 1.81
Renal transplantation. BMJ (2002) 1.80
Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant (2011) 1.79
Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol (2009) 1.77
Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol (2010) 1.76
Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg (2005) 1.76
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Optimizing renal replacement therapy in older adults: a framework for making individualized decisions. Kidney Int (2011) 1.73
Attitudes toward strategies to increase organ donation: views of the general public and health professionals. Clin J Am Soc Nephrol (2012) 1.66
Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol (2009) 1.66
Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant (2010) 1.65
Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol (2008) 1.62
Access to kidney transplantation among the elderly in the United States: a glass half full, not half empty. Clin J Am Soc Nephrol (2010) 1.62
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation. Kidney Int (2013) 1.61
Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol (2011) 1.61
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
Death and renal transplantation among Aboriginal people undergoing dialysis. CMAJ (2004) 1.56
Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrol Dial Transplant (2012) 1.55
Trends in kidney transplant outcomes in older adults. J Am Geriatr Soc (2014) 1.53
Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation. PLoS One (2014) 1.52
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Longitudinal Studies of a B Cell-Derived Signature of Tolerance in Renal Transplant Recipients. Am J Transplant (2015) 1.52
Relationship between patients' perceptions of disadvantage and discrimination and listing for kidney transplantation. Am J Public Health (2002) 1.51
Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Liver Transpl (2014) 1.50
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. BMJ (2014) 1.50
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int (2015) 1.50
Residence location and likelihood of kidney transplantation. CMAJ (2006) 1.49
iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment. Transplantation (2016) 1.49
Functional Status, Time to Transplantation, and Survival Benefit of Kidney Transplantation Among Wait-Listed Candidates. Am J Kidney Dis (2015) 1.47
Equity versus efficiency: a dilemma for the NHS. If the NHS is serious about equity it must offer guidance when principles conflict. BMJ (2001) 1.46
Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists. JAMA Intern Med (2013) 1.46
Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res (2013) 1.46
Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant (2009) 1.45
Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. J Am Soc Nephrol (2008) 1.45
Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol (2011) 1.45
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
Standardized deceased donor kidney donation rates in the UK reveal marked regional variation and highlight the potential for increasing kidney donation: a prospective cohort study†. Br J Anaesth (2013) 1.43
Effect of comorbidity adjustment on CMS criteria for kidney transplant center performance. Am J Transplant (2009) 1.43
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
Graft and patient survival outcomes of a third kidney transplant. Transplantation (2015) 1.41
Increased rates of donation with laparoscopic donor nephrectomy. Ann Surg (2000) 1.40
Report card on renal transplantation. CMAJ (2000) 1.39
Addressing racial and ethnic disparities in live donor kidney transplantation: priorities for research and intervention. Semin Nephrol (2010) 1.39
Tolerance of Vascularized Islet-Kidney Transplants in Rhesus Monkeys. Am J Transplant (2016) 1.39
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Kidney transplantation in the elderly. Semin Nephrol (2009) 1.27
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.26
A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One (2010) 1.25
Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America. Pediatr Nephrol (2006) 1.23
Disparities in kidney transplant outcomes: a review. Semin Nephrol (2010) 1.21
End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ (2007) 1.21
Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes (2004) 1.21
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics (2009) 1.18
Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci U S A (2009) 1.18
Association of race and insurance type with delayed assessment for kidney transplantation among patients initiating dialysis in the United States. Clin J Am Soc Nephrol (2012) 1.18
Belatacept: A worthy alternative to cyclosporine? J Pharmacol Pharmacother (2012) 1.17
MDCT evaluation of potential living renal donor, prior to laparoscopic donor nephrectomy: What the transplant surgeon wants to know? Indian J Radiol Imaging (2014) 1.17
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol (2015) 1.15
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) (2008) 1.15
Racial disparities in renal replacement therapy. J Natl Med Assoc (2002) 1.15
Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation. PLoS One (2010) 1.14
Old age, life extension, and the character of medical choice. J Gerontol B Psychol Sci Soc Sci (2006) 1.14
Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J Am Soc Nephrol (2013) 1.13
Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled Trial. JMIR Res Protoc (2013) 1.13
Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis (2010) 1.12
Physical function in older candidates for renal transplantation: an impaired population. Clin J Am Soc Nephrol (2009) 1.11
Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol (2009) 1.11
Can new-onset diabetes after kidney transplant be prevented? Diabetes Care (2013) 1.10
Attitudes and acceptance of First Person Authorization: a national comparison of donor and nondonor families. J Trauma Acute Care Surg (2013) 1.10
Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol (2015) 1.09
Promoting access to renal transplantation: the role of social support networks in completing pre-transplant evaluations. J Gen Intern Med (2008) 1.08
Impact of normothermic preservation with extracellular type solution containing trehalose on rat kidney grafting from a cardiac death donor. PLoS One (2012) 1.07
A decade of experience with renal transplantation in African-Americans. Ann Surg (2002) 1.06
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol (2008) 1.06
Patient- and provider-reported information about transplantation and subsequent waitlisting. J Am Soc Nephrol (2014) 1.06
Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities. Am J Nephrol (2014) 1.06
Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol (2013) 1.05
Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg (2004) 1.04
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc (2004) 1.04
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol (2010) 1.03
Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant (2009) 1.02
Commercial renal transplantation: A risky venture? A single Canadian centre experience. Can Urol Assoc J (2011) 1.02
Obesity management in adults with CKD. Am J Kidney Dis (2009) 1.02
2202 kidney transplant recipients with 10 years of graft function: what happens next? Am J Transplant (2008) 1.02
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
A compendium of gene expression in normal human tissues. Physiol Genomics (2001) 5.66
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Transmission of hepatitis C virus by organ transplantation. N Engl J Med (1991) 5.17
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (1990) 4.40
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med (1992) 2.78
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Organ donation and utilization in the United States, 1999-2008. Am J Transplant (2010) 2.33
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res (1999) 1.78
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant (2008) 1.75
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation (1997) 1.71
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Reimbursing live organ donors for incurred non-medical expenses: a global perspective on policies and programs. Am J Transplant (2009) 1.46
Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis (1992) 1.45
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders. Q J Med (1989) 1.43
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Hemodialysis vascular access morbidity in the United States. Kidney Int (1993) 1.41
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol (1994) 1.40
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int (1992) 1.38
Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant (2008) 1.38
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
A novel united network for organ sharing region kidney allocation plan improves transplant access for minority candidates. Transplantation (1999) 1.37
New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci. Nature (1992) 1.36
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
Association of gender and access to cadaveric renal transplantation. Am J Kidney Dis (1997) 1.33
Containing Medicaid costs in an era of growing physician supply. Health Care Financ Rev (1985) 1.33
Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int (1973) 1.32
Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis (1997) 1.29
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int (1996) 1.27
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26